Irish-founded Aer Therapeutics raises $36m for COPD treatment
Founded by researchers based in UCD and San Francisco, Aer is developing a novel drug to help COPD patients breathe easier.
Source: siliconrepublic.com
Stay updated with breaking news from Prof Stefan Oscarson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Founded by researchers based in UCD and San Francisco, Aer is developing a novel drug to help COPD patients breathe easier.
Company was co-founded by Irishman Prof John Fahy of University of California, San Francisco and Prof Stefan Oscarson of UCD
Aer Therapeutics receives money from a syndicate of premier life science industry investors
Prof Stefan Oscarson and Prof Stephen Carrington won for developing a new drug for mucus-related issues for patients with lung conditions.